Blog · 21 Jul 2026
Sun Pharma is marrying Organon
In today’s Finshots, we briefly explain Sun Pharma’s acquisition of Organon.But here’s a quick sidenote before we begin.
In today’s Finshots, we briefly explain Sun Pharma’s acquisition of Organon.But here’s a quick sidenote before we begin.
If you’re someone who loves keeping tabs on the world of business and finance, hit subscribe if you haven’t already. And if you’re already a subscriber, thank you! Maybe forward this to someone who’d enjoy our stories but hasn’t discovered us yet.Now, on to today’s story.The StoryA few days ago, the largest overseas pharmaceutical deal in India’s history was announced. Sun Pharmaceutical Industries said it would acquire US-based Organon & Co.
for $11.75 billion.So let’s skip the fluff and get straight to the meat of this deal.Sun Pharma needs little introduction. There’s a good chance you’ve used its medicines, whether it’s Volini Gel for aches and pains or Pantocid, the generic version of a patented drug used to treat acidity.But Sun Pharma isn’t just a branded generics player. And it didn’t start out as one either.